A. C. Loweth

发表

Evidence for the involvement of cGMP and protein kinase G in nitric oxide‐induced apoptosis in the pancreatic B‐cell line, HIT‐T15

N. Morgan, G. Williams, G.T. Williams, 1997, FEBS letters.

Oxidative and nitrosative stress in β-cell apoptosis: their contribution to β-cell lossin type 1 diabetes mellitus

A. C. Loweth, D. Watson, 2009 .

Oxidative and nitrosative stress in beta-cell apoptosis: their contribution to beta-cell loss in type 1 diabetes mellitus.

A. C. Loweth, D. Watson, 2009, British journal of biomedical science.

Superoxide, nitric oxide, peroxynitrite and cytokine combinations all cause functional impairment and morphological changes in rat islets of Langerhans and insulin secreting cell lines, but dictate cell death by different mechanisms

N. Morgan, J. Mabley, J. Thorpe, 2004, Apoptosis.

Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation.

N. Morgan, G. Williams, R. James, 1998, Diabetes.

A specific inhibitor of cytosolic phospholipase A2 activity, AACOCF3, inhibits glucose-induced insulin secretion from isolated rat islets.

N. Morgan, J. Scarpello, A. C. Loweth, 1996, Biochemical and biophysical research communications.

Heterotrimeric G-proteins are implicated in the regulation of apoptosis in pancreatic beta-cells.

N. Morgan, G. Williams, J. Scarpello, 1996, Experimental cell research.

Phospholipase A2 expression in human and rodent insulin-secreting cells

N. Morgan, J. Scarpello, A. C. Loweth, 1995, Molecular and Cellular Endocrinology.

Dissociation between Fas expression and induction of apoptosis in human islets of Langerhans

N. Morgan, G. Williams, S. McBain, 2000, Diabetes, obesity & metabolism.

Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus

N. Morgan, I. Todd, P. Radford, 2001, Clinical and experimental immunology.

Stimulation of insulin secretion by imidazoline compounds is not due to interaction with non‐adrenoceptor idazoxan binding sites

N. Morgan, Stephen A. Smith, A. C. Loweth, 1993, British journal of pharmacology.